← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. TCMD
  3. P/E History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

TCMD logoTactile Systems Technology, Inc. (TCMD) P/E Ratio History

Historical price-to-earnings valuation from 2016 to 2026

Current P/E
31.7
Undervalued
5Y Avg P/E
101.4
-69% vs avg
PE Percentile
50%
Average
PEG Ratio
N/A
N/A
TTM EPS$0.90
Price$26.01
5Y PE Range8.7 - 919.9
Earnings Yield3.15%

Loading P/E history...

TCMD Valuation Context

How does the current P/E compare to historical and market benchmarks?

vs. 5Y Average
31.7vs101.4
-69%
Cheap vs History
vs. Healthcare
31.7vs22.3
+42%
Above Sector
vs. S&P 500
31.7vs25.1
+26%
Above Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 17% EPS growth (1Y)
Export Data

P/E Ratio Analysis

As of May 8, 2026, Tactile Systems Technology, Inc. (TCMD) trades at a price-to-earnings ratio of 31.7x, with a stock price of $26.01 and trailing twelve-month earnings per share of $0.90.

The current P/E is 69% below its 5-year average of 101.4x. Over the past five years, TCMD's P/E has ranged from a low of 8.7x to a high of 919.9x, placing the current valuation at the 50th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.3x, TCMD trades at a 42% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.

Relative to the broader market, TCMD commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our TCMD DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

TCMD P/E vs Peers

P/E ratio compared to closely matched public peers

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
LNTH logoLNTHLantheus Holdings, Inc.
$6B26.7--22%
ITGR logoITGRInteger Holdings Corporation
$3B30.46.91-15%
MMSI logoMMSIMerit Medical Systems, Inc.
$4B29.3-+5%
CNMD logoCNMDCONMED Corporation
$1B25.20.69-65%
ABT logoABTAbbott Laboratories
$151B11.4Lowest0.38Best+134%Best
MDT logoMDTMedtronic plc
$100B21.6-+31%
BSX logoBSXBoston Scientific Corporation
$84B29.2-+55%

Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.

TCMD Historical P/E Data (2016–2026)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterDatePriceTTM EPSP/E Ratiovs Avg
FY2026 Q1$26.13$0.8829.7x-73%
FY2025 Q4Wed Dec 31 2025 00:00:00 GM$29.00$0.8334.9x-68%
FY2025 Q3$13.84$0.7718.0x-84%
FY2025 Q2Mon Jun 30 2025 00:00:00 GM$10.14$0.6216.4x-85%
FY2025 Q1Mon Mar 31 2025 00:00:00 GM$13.22$0.6620.0x-82%
FY2024 Q4$17.13$0.7024.5x-78%
FY2024 Q3Mon Sep 30 2024 00:00:00 GM$14.61$0.6522.5x-79%
FY2024 Q2Sun Jun 30 2024 00:00:00 GM$11.94$1.388.7x-92%
FY2024 Q1Sun Mar 31 2024 00:00:00 GM$16.25$1.2013.6x-88%
FY2023 Q4Sun Dec 31 2023 00:00:00 GM$14.30$1.2011.9x-89%
FY2023 Q3Sat Sep 30 2023 00:00:00 GM$14.05$1.0813.0x-88%
FY2023 Q2Fri Jun 30 2023 00:00:00 GM$24.93$0.03919.9x+741%

Average P/E for displayed period: 109.3x

See TCMD's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is TCMD Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare TCMD vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

TCMD — Frequently Asked Questions

Quick answers to the most common questions about buying TCMD stock.

Is TCMD stock overvalued or undervalued?

TCMD trades at 31.7x P/E, below its 5-year average of 101.4x. At the 50th percentile of historical range, the stock is priced at a discount to its own history.

How does TCMD's valuation compare to peers?

Tactile Systems Technology, Inc. P/E of 31.7x compares to sector median of 22.3x. The premium reflects expected growth above peers.

What is TCMD's PEG ratio?

TCMD PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2016-2026.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

TCMD P/E Ratio History (2016–2026)

P/E ratio calculated as closing price divided by trailing 12-month diluted EPS at each quarter end.